|
Intel Announces its First Home Medical Device in the United Kingdom to Better Connect Clinicians With Patients
LONDON, November 20, 2008 /PRNewswire via COMTEX/ --
- Intel(R) Health Guide is the First Product in a Series Designed to
Enable More Personalised Care Management for Chronic and Age-related
Conditions
Intel Corporation today announced the Intel(R) Health Guide, a care
management tool designed for healthcare professionals who treat patients with
chronic conditions, for the UK. The Intel Health Guide represents Intel's
entry into a new category of personal health systems that go beyond the
simple remote patient monitoring systems available today.
To view the Multimedia News Release, please click:
http://www.prnewswire.com/mnr/Intel/36076/
The Intel Health Guide, a regulated device that carries the CE mark under
the EU Medical Device Directive, is a comprehensive personal health system
that combines an in-home patient device - the Intel Health Guide PHS6000 - as
well as an online interface - the Intel(R) Health Care Management Suite -
allowing clinicians to monitor patients in their homes and manage care
remotely. Additional localised European language versions of the Intel Health
Guide will be announced throughout 2009.
"The Intel Health Guide is a step forward in offering more personalised
and effective management of chronic health conditions in the home," said
Louis Burns, vice president and general manager of the Intel Digital Health
Group. "Intel has spent years researching the needs of healthcare
professionals, carers and patients, and we are now moving to launch a series
of products that will help extend care from the hospital to the home. Our
products will help address the challenges of an ageing population and rising
rates of chronic disease."
The Intel Health Guide promotes greater patient engagement and more
efficient care by enabling communication between patients and healthcare
professionals and providing clinicians with access to the most current,
actionable data. The solution offers interactive tools for personalised care
management and includes vital sign collection, patient reminders, surveys,
multimedia educational content, and feedback and communications tools, such
as video conferencing and alerts. Clinicians have ongoing access to data so
that they can better manage each patient's condition while patients benefit
from customised care in the comfort of their own home.
Intel is collaborating with healthcare industry leaders in Europe to
demonstrate the clinical benefits of the Intel Health Guide for a wide range
of chronic conditions. European pilots are under way with healthcare
organisations such as NHS Lothian, UK, the Institute for Prevention and
Telemedicine (IPT) and the Academic Medical Center (AMC), Amsterdam, The
Netherlands. The objective is to assess how the Health Guide integrates with
different care management models in the home. These first studies focus on
the ability to demonstrate improved health outcomes for conditions such as
chronic obstructive pulmonary disease (COPD) and heart failure.
Martin Egan, Director of eHealth, NHS Lothian said, "We are delighted to
be at the heart of this pioneering work through our pilot programme. Initial
findings show that patients experience additional reassurance from the
telehealth system and the early indications around the reduction of hospital
admissions look promising. We are now working toward the expansion of the
programme across Lothian."
The pilot in The Netherlands is a cooperative effort between the Academic
Medical Center (AMC) in Amsterdam, the Institute for Prevention and
Telemedicine (IPT) and Intel. The project involves cardiologists and patients
from the congestive heart failure (CHF) outpatient clinic of the AMC under
the supervision of Professor Bas de Mol, Head of the Department of
Cardiothoracic Surgery.
Intel is also working with leading organisations that have an
understanding of healthcare delivery to develop unique patient care plans as
well as multimedia educational content for chronic conditions. In the UK,
Intel has worked with the Map of Medicine and using their existing pathways
developed care plans for use on the Intel Health Guide that are based on best
practice and evidence to help patients and their clinicians effectively
manage their condition at home. Care plans were developed for a number of
chronic conditions including diabetes, heart failure and COPD.
Tunstall Healthcare Group, a leading provider of telecare and telehealth
solutions, is the first official market channel partner for the Intel Health
Guide in the UK. James Buckley, Tunstall CEO said, "By adding the Intel
Health Guide to our portfolio of healthcare offerings, Tunstall will be
further equipped to provide its customers with the best in care management
solutions." Intel is also currently working with other leading market channel
partners in the UK to bring the Intel Health Guide to market.
The Intel Health Guide is designed to be used by healthcare professionals
to manage their patients' health at home and is not currently available for
general consumer purchase. The Intel Health Guide received 510(k) market
clearance from the U.S. Food and Drug Administration (FDA) in July 2008 and
was announced on Nov. 10, 2008 in the U.S.
Additionally, Intel plans to use the core technology components of the
solution to build products targeted for new areas such as independent living
and programmes for health and wellbeing management, and to support new
devices such as mobile phones and handhelds.
For More Information
For more information on the Intel Health Guide, visit
http://www.intel.com/healthcare/telehealth.
To learn more about Intel in healthcare, go to
http://www.intel.com/healthcare.
About Intel
Intel (NASDAQ: INTC), the world leader in silicon innovation, develops
technologies, products and initiatives to continually advance how people work
and live. Additional information about Intel is available at
http://www.intel.com/pressroom and blogs.intel.com.
Intel is a trademark of Intel Corporation or its subsidiaries in the
United States and other countries.
* Other names and brands may be claimed as the property of other
Contacts:
Diana Kaaserer Bea Solomon
Intel Corporation Hill and Knowlton
+49-8999143860 +44-2074133185
diana.kaaserer@intel.com bsolomon@hillandknowlton.com
SOURCE Intel Corporation
[ InfoTech Spotlight's Homepage ]
|
